查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1555647

介入性腫瘤學市場：2024-2031年全球產業分析、規模、佔有率、成長、趨勢、預測

Interventional Oncology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 196 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於全球介入腫瘤學市場的詳細報告。本報告對市場驅動因素、趨勢、機會和挑戰等關鍵市場動態進行了全面分析，提供了對市場結構的深入見解。

主要見解

  • 介入性腫瘤學市場規模（2024年）：21億美元
  • 預測市場規模（2031年）：35億美元
  • 全球市場成長率（2024-2031年年複合成長率）：8.1%

介入性腫瘤學市場：研究範圍

介入性腫瘤學市場包括利用射頻消融、冷凍消融和微波消融等先進技術進行癌症治療的微創手術。這些技術目的是減少患者的不適和恢復時間，同時提供有效的腫瘤靶向，並推動醫院、診所和家庭健康環境對此類治療的需求。癌症盛行率上升、影像技術進步以及對以患者為中心的護理的日益關注推動了市場成長。鎮靜、疼痛管理和監測技術的創新改善患者的整體治療體驗，進一步推動市場擴張。

推動市場成長的因素：

全球介入腫瘤學市場主要是由癌症盛行率的增加和微創治療的日益採用所推動的。診斷影像和介入設備的技術進步提高手術的準確性和安全性，有助於改善患者的治療結果。此外，隨著患者和醫療保健提供者越來越喜歡恢復更快、併發症更少的侵入性較小的治療方法，對標靶癌症治療的需求上升。設備技術的創新和對個人化癌症治療的日益重視也推動了市場成長，研發投資推動新技術的發展。

市場限制因素：

儘管介入腫瘤學市場成長前景廣闊，但仍面臨挑戰，包括低收入和中等收入國家獲得先進治療的機會有限。醫療保健基礎設施不足、專家短缺以及尖端設備成本高昂限制了資源貧乏地區對這些治療方法的採用。此外，在獲得現代介入腫瘤學技術方面的差異阻礙了患者的治療效果，特別是在發展中國家。解決這些障礙需要世界各地大力改善醫療基礎設施、培訓和先進癌症治療的可用性。

市場機會：

介入性腫瘤學市場存在巨大的商機，特別是隨著對個人化醫療和家庭護理的需求不斷成長。 MRI 和 CT 掃描等診斷影像工具的創新提高腫瘤靶向的準確性，並創造進一步的市場成長機會。電子商務平台和直接面向消費者的管道的擴展也使這些技術更容易獲得，特別是在偏遠地區。此外，與醫療保健提供者和健康中心的合作推動介入腫瘤設備的採用，進一步支持市場擴張。

本報告涵蓋的主要問題

  • 推動介入性腫瘤學市場全球成長的關鍵因素是什麼？
  • 哪些產品類型在市場上成長最快，例如消融設備？
  • 影像技術和病患監測的進步如何影響介入性腫瘤學市場的競爭格局？
  • 誰是介入腫瘤學市場的主要參與者？他們保持競爭力的策略是什麼？
  • 介入性腫瘤市場的新趨勢和未來前景是什麼？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍與定義
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 課題
    • 主要趨勢
  • 宏觀經濟因素
    • 世界產業展望
    • 世界 GDP 成長前景
    • 全球醫療保健支出前景
  • 新冠肺炎（COVID-19）影響分析
  • 預測因子 - 相關性和影響

第3章 增值見解

  • 監理狀況
  • 產品採用率分析
  • 價值鏈分析
  • 主要交易和合併
  • PESTLE分析
  • 波特五力分析

第4章 全球介入性腫瘤學市場展望：過去（2019-2023年）與預測（2024-2031年）

  • 主要亮點
    • 市場規模（十億美元）和年成長率
    • 絕對的獲利機會
  • 市場規模分析與預測（十億美元）
    • 2019-2023年市場規模（十億美元）分析
    • 2023-2031年市場規模（十億美元）分析與預測
  • 全球介入性腫瘤學市場展望：產品
    • 簡介/主要調查結果
    • 2019-2023年市場規模（十億美元）分析
    • 2024-2031年市場規模（十億美元）分析與預測
      • 放射治療設備
      • 消融裝置
        • 微波消融
        • 射頻消融術
        • 冷凍療法
        • 其他
      • 栓塞裝置
        • 微導管
        • 導絲
  • 市場吸引力分析：產品
  • 全球介入性腫瘤學市場展望：癌症類型
    • 簡介/主要調查結果
    • 2019-2023年市場規模（十億美元）分析
    • 2024-2031年市場規模（十億美元）分析與預測
      • 肺癌
      • 肝癌
      • 腎癌
      • 其他
  • 市場吸引力分析：癌症類型
  • 全球介入腫瘤學市場展望：最終用戶
    • 簡介/主要調查結果
    • 2019-2023年市場規模（十億美元）分析
    • 2024-2031年市場規模（十億美元）分析與預測
      • 醫院
      • 專科診所
      • 門診手術中心
      • 其他
  • 市場吸引力分析：最終用戶

第5章 全球介入性腫瘤學市場展望：地區

  • 主要亮點
  • 2019-2023年市場規模（十億美元）分析
  • 2024-2031年市場規模（十億美元）分析與預測
    • 北美
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東、非洲
  • 市場吸引力分析：地區

第6章 北美介入性腫瘤學市場展望：過去（2019-2023年）與預測（2024-2031年）

第7章 歐洲介入腫瘤學市場展望：過去（2019-2023年）與預測（2024-2031年）

第8章 東亞介入腫瘤學市場展望：過去（2019-2023年）與預測（2024-2031年）

第9章 南亞和大洋洲介入腫瘤學市場展望：過去（2019-2023年）和預測（2024-2031年）

第10章 拉丁美洲介入腫瘤學市場展望：過去（2019-2023年）與預測（2024-2031年）

第11章 中東與非洲介入腫瘤學市場展望：過去（2019-2023年）與預測（2024-2031年）

第12章 競爭態勢

  • 2023年市佔率分析
  • 市場結構
    • 依市場劃分的競爭強度圖
    • 競爭儀表板
  • 公司簡介（詳細資料 - 概述、財務狀況、策略、近期發展）
    • Profound Medical
    • Medtronic Plc.
    • Hologic, Inc.
    • Boston Scientific Corporation
    • AngioDynamics
    • Terumo Corporation
    • Teleflex Incorporated
    • Alpinion Medical Systems Co. Ltd.
    • Siemens Healthineers
    • Merit Medical

第13章 附錄

  • 調查方法
  • 調查假設
  • 首字母縮寫詞和縮寫詞
簡介目錄
Product Code: PMRREP34749

Persistence Market Research has recently published an extensive report on the global Interventional Oncology Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • Interventional Oncology Market Size (2024E): USD 2.1 Bn
  • Projected Market Value (2031F): USD 3.5 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 8.1%

Interventional Oncology Market - Report Scope:

The Interventional Oncology Market involves the application of minimally invasive procedures for cancer treatment, utilizing advanced technologies such as radiofrequency ablation, cryoablation, and microwave ablation. These techniques aim to reduce patient discomfort and recovery time while providing effective tumor targeting, driving demand for such treatments in hospitals, clinics, and homecare settings. The market growth is propelled by the rising prevalence of cancer, technological advancements in imaging, and a growing focus on patient-centric care. Innovations in sedation, pain management, and monitoring technologies further support market expansion, enhancing the overall procedural experience for patients.

Market Growth Drivers:

The global Interventional Oncology Market is primarily driven by the increasing prevalence of cancer and the growing adoption of minimally invasive treatments. Technological advancements in imaging and interventional devices are enhancing procedural accuracy and safety, contributing to better patient outcomes. Furthermore, the demand for targeted cancer therapies is on the rise as patients and healthcare providers increasingly prefer less invasive treatment options that offer quicker recovery times and reduced complications. Innovations in device technology and the growing emphasis on personalized cancer treatments are also fueling market growth, with investments in research and development advancing new techniques.

Market Restraints:

Despite its promising growth, the Interventional Oncology Market faces challenges such as limited accessibility to advanced treatments in low and middle-income countries. Inadequate healthcare infrastructure, a shortage of specialized professionals, and the high cost of state-of-the-art equipment restrict the adoption of these treatments in resource-constrained regions. Moreover, disparities in access to the latest interventional oncology technologies hinder patient outcomes, particularly in developing nations. Addressing these barriers will require focused efforts to improve healthcare infrastructure, training, and the availability of advanced cancer care worldwide.

Market Opportunities:

Significant opportunities exist within the Interventional Oncology Market, especially with the increasing demand for personalized and home-based healthcare solutions. Innovations in imaging tools, including MRI and CT scans, are enhancing the precision of tumor targeting, creating opportunities for further market growth. The expansion of e-commerce platforms and direct-to-consumer sales channels is also providing easier access to these technologies, particularly in remote areas. Additionally, collaborations with healthcare providers and wellness centers are promoting the adoption of interventional oncology devices, further driving market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Interventional Oncology Market globally?
  • Which product types, such as ablation devices, are expanding the most in the market?
  • How are advancements in imaging technologies and patient monitoring influencing the competitive landscape of the Interventional Oncology Market?
  • Who are the key players in the Interventional Oncology Market, and what strategies are they using to maintain their competitive edge?
  • What are the emerging trends and future prospects in the global Interventional Oncology Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Interventional Oncology Market are focusing on innovation, strategic collaborations, and research and development to maintain a competitive edge. Companies are investing in the development of advanced ablation devices and exploring new product formats to meet evolving patient needs. Collaborations with hospitals, clinics, and healthcare providers help facilitate the adoption of these technologies, while marketing strategies emphasize consumer education and high-quality products. These efforts, combined with a focus on improving patient outcomes and minimizing recovery times, are contributing to sustained growth in the Interventional Oncology Market.

Key Market Players

  • Profound Medical
  • Medtronic Plc.
  • Hologic, Inc.
  • Boston Scientific Corporation
  • AngioDynamics
  • Terumo Corporation
  • Teleflex Incorporated
  • Alpinion Medical Systems Co. Ltd.
  • Siemens Healthineers
  • Merit Medical

Interventional Oncology Industry Segmentation

By Product

  • Radiation Therapy Devices
  • Ablation Devices
  • Embolization Devices

By Cancer Type

  • Lung Cancer
  • Liver Cancer
  • Kidney Cancer
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centre

By Region

  • North America
  • Europe
  • Asia Pacific
  • The Middle East and Africa
  • Latin America

Table of Contents

1. Executive Summary

  • 1.1. Global Interventional Oncology Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Product Adoption Analysis
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Global Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
    • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
  • 4.3. Global Interventional Oncology Market Outlook: Product
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2023
    • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
      • 4.3.3.1. Radiation Therapy Devices
      • 4.3.3.2. Ablation Devices
        • 4.3.3.2.1. Microwave ablation
        • 4.3.3.2.2. Radiofrequency ablation
        • 4.3.3.2.3. Cryoablation
        • 4.3.3.2.4. Others
      • 4.3.3.3. Embolization Devices
        • 4.3.3.3.1. Microcatheters
        • 4.3.3.3.2. Guidewires
  • 4.4. Market Attractiveness Analysis: Product
  • 4.5. Global Interventional Oncology Market Outlook: Cancer Type
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By Cancer Type, 2019-2023
    • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
      • 4.5.3.1. Lung Cancer
      • 4.5.3.2. Liver Cancer
      • 4.5.3.3. Kidney Cancer
      • 4.5.3.4. Others
  • 4.6. Market Attractiveness Analysis: Cancer Type
  • 4.7. Global Interventional Oncology Market Outlook: End User
    • 4.7.1. Introduction / Key Findings
    • 4.7.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
    • 4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
      • 4.7.3.1. Hospitals
      • 4.7.3.2. Specialty Clinics
      • 4.7.3.3. Ambulatory Surgical Center
      • 4.7.3.4. Others
  • 4.8. Market Attractiveness Analysis: End User

5. Global Interventional Oncology Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
  • 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024-2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 6.2.1. By Country
    • 6.2.2. By Product
    • 6.2.3. By Cancer Type
    • 6.2.4. By Route of Administration
    • 6.2.5. By End User
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 6.4.1. Radiation Therapy Devices
    • 6.4.2. Ablation Devices
      • 6.4.2.1. Microwave ablation
      • 6.4.2.2. Radiofrequency ablation
      • 6.4.2.3. Cryoablation
      • 6.4.2.4. Others
    • 6.4.3. Embolization Devices
      • 6.4.3.1. Microcatheters
      • 6.4.3.2. Guidewires
  • 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
    • 6.5.1. Lung Cancer
    • 6.5.2. Liver Cancer
    • 6.5.3. Kidney Cancer
    • 6.5.4. Others
  • 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 6.6.1. Hospitals
    • 6.6.2. Specialty Clinics
    • 6.6.3. Ambulatory Surgical Center
    • 6.6.4. Others
  • 6.7. Market Attractiveness Analysis

7. Europe Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Cancer Type
    • 7.2.4. By Route of Administration
    • 7.2.5. By End User
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 7.4.1. Radiation Therapy Devices
    • 7.4.2. Ablation Devices
      • 7.4.2.1. Microwave ablation
      • 7.4.2.2. Radiofrequency ablation
      • 7.4.2.3. Cryoablation
      • 7.4.2.4. Others
    • 7.4.3. Embolization Devices
      • 7.4.3.1. Microcatheters
      • 7.4.3.2. Guidewires
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
    • 7.5.1. Lung Cancer
    • 7.5.2. Liver Cancer
    • 7.5.3. Kidney Cancer
    • 7.5.4. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 7.6.1. Hospitals
    • 7.6.2. Specialty Clinics
    • 7.6.3. Ambulatory Surgical Center
    • 7.6.4. Others
  • 7.7. Market Attractiveness Analysis

8. East Asia Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Cancer Type
    • 8.2.4. By Route of Administration
    • 8.2.5. By End User
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 8.4.1. Radiation Therapy Devices
    • 8.4.2. Ablation Devices
      • 8.4.2.1. Microwave ablation
      • 8.4.2.2. Radiofrequency ablation
      • 8.4.2.3. Cryoablation
      • 8.4.2.4. Others
    • 8.4.3. Embolization Devices
      • 8.4.3.1. Microcatheters
      • 8.4.3.2. Guidewires
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
    • 8.5.1. Lung Cancer
    • 8.5.2. Liver Cancer
    • 8.5.3. Kidney Cancer
    • 8.5.4. Others
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 8.6.1. Hospitals
    • 8.6.2. Specialty Clinics
    • 8.6.3. Ambulatory Surgical Center
    • 8.6.4. Others
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Cancer Type
    • 9.2.4. By Route of Administration
    • 9.2.5. By End User
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 9.4.1. Radiation Therapy Devices
    • 9.4.2. Ablation Devices
      • 9.4.2.1. Microwave ablation
      • 9.4.2.2. Radiofrequency ablation
      • 9.4.2.3. Cryoablation
      • 9.4.2.4. Others
    • 9.4.3. Embolization Devices
      • 9.4.3.1. Microcatheters
      • 9.4.3.2. Guidewires
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
    • 9.5.1. Lung Cancer
    • 9.5.2. Liver Cancer
    • 9.5.3. Kidney Cancer
    • 9.5.4. Others
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 9.6.1. Hospitals
    • 9.6.2. Specialty Clinics
    • 9.6.3. Ambulatory Surgical Center
    • 9.6.4. Others
  • 9.7. Market Attractiveness Analysis

10. Latin America Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Cancer Type
    • 10.2.4. By Route of Administration
    • 10.2.5. By End User
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 10.4.1. Radiation Therapy Devices
    • 10.4.2. Ablation Devices
      • 10.4.2.1. Microwave ablation
      • 10.4.2.2. Radiofrequency ablation
      • 10.4.2.3. Cryoablation
      • 10.4.2.4. Others
    • 10.4.3. Embolization Devices
      • 10.4.3.1. Microcatheters
      • 10.4.3.2. Guidewires
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
    • 10.5.1. Lung Cancer
    • 10.5.2. Liver Cancer
    • 10.5.3. Kidney Cancer
    • 10.5.4. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 10.6.1. Hospitals
    • 10.6.2. Specialty Clinics
    • 10.6.3. Ambulatory Surgical Center
    • 10.6.4. Others
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Interventional Oncology Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Cancer Type
    • 11.2.4. By Route of Administration
    • 11.2.5. By End User
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product, 2024-2031
    • 11.4.1. Radiation Therapy Devices
    • 11.4.2. Ablation Devices
      • 11.4.2.1. Microwave ablation
      • 11.4.2.2. Radiofrequency ablation
      • 11.4.2.3. Cryoablation
      • 11.4.2.4. Others
    • 11.4.3. Embolization Devices
      • 11.4.3.1. Microcatheters
      • 11.4.3.2. Guidewires
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2024-2031
    • 11.5.1. Lung Cancer
    • 11.5.2. Liver Cancer
    • 11.5.3. Kidney Cancer
    • 11.5.4. Others
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 11.6.1. Hospitals
    • 11.6.2. Specialty Clinics
    • 11.6.3. Ambulatory Surgical Center
    • 11.6.4. Others
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Profound Medical
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Medtronic Plc.
    • 12.3.3. Hologic, Inc.
    • 12.3.4. Boston Scientific Corporation
    • 12.3.5. AngioDynamics
    • 12.3.6. Terumo Corporation
    • 12.3.7. Teleflex Incorporated
    • 12.3.8. Alpinion Medical Systems Co. Ltd.
    • 12.3.9. Siemens Healthineers
    • 12.3.10. Merit Medical

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations